HT
SPPI

HAP Trading’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

HAP Trading’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,700
Closed -$1K – 1435
2023
Q1 		$1K Sell
17,700
-13,000
-42% -$9.48K ﹤0.01% 1129
2022
Q4 		$1K Sell
30,700
-700
-2% -$295 ﹤0.01% 1463
2022
Q3 		$2K Sell
31,400
-3,800
-11% -$3.73K ﹤0.01% 1618
2022
Q2 		$5K Buy
35,200
+17,900
+103% +$15.8K ﹤0.01% 1643
2022
Q1 		$3K Buy
+17,300
New +$15.9K ﹤0.01% 2050
2021
Q3 		– Sell
-17,600
Closed -$4K – 2868
2021
Q2 		$4K Buy
17,600
+1,700
+11% +$5.91K ﹤0.01% 2203
2021
Q1 		$4K Buy
15,900
+1,900
+14% +$6.81K ﹤0.01% 1798
2020
Q4 		$2K Sell
14,000
-9,100
-39% -$37.5K ﹤0.01% 2135
2020
Q3 		$11K Buy
+23,100
New +$87.8K ﹤0.01% 1315
2020
Q1 		– Sell
-20,900
Closed -$1K – 1585
2019
Q4 		$1K Buy
+20,900
New +$169K ﹤0.01% 1201

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's SPPI Position: Q1 2018 in Review

HAP Trading sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2018, closing a stake of 31,733 shares — an estimated $601K sold.

HAP Trading first reported a position in SPPI in Q4 2017 and held it in 1 quarter. The position peaked at $601K in Q4 2017. 161 funds tracked by Wall St. Rank hold SPPI as of Q1 2018.

  • HAP Trading reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
  • HAP Trading sold 31,733 Spectrum Pharmaceuticals Inc shares in Q1 2018, an estimated $601K.
  • HAP Trading first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 1 quarter.
  • HAP Trading's Spectrum Pharmaceuticals Inc position peaked at $601K in Q4 2017.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2018.

Based on HAP Trading's 13F filing for Q1 2018, filed 11 May 2018.